1

Daratumumab 945721-28-8: A Deep Dive into its Properties

daratumumab265312
This medication identified as 945721-28-8 represents a groundbreaking monoclonal antibody, specifically designed to target CD38, an antigen ubiquitously expressed the surface of blood cells. Its mode of activity https://www.targetmol.com/compound/daratumumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story